MONDAY, June 10 (HealthDay News) -- An implanted device that
zaps the nerves at the nape of the neck -- shown effective in
treating some people with migraines -- may also help ease the ache
of fibromyalgia, an ailment that causes widespread body pain and
A Belgian scientist treated small numbers of fibromyalgia
patients with "occipital nerve stimulation," which rouses the
occipital nerves just beneath the skin at the back of the neck
using an implanted device. Dr. Mark Plazier found that pain scores
dropped for 20 of 25 patients using this device over six months and
their quality of life improved significantly.
"There are only a few treatment options [for fibromyalgia] right now and the response to treatment is far from 100 percent, which implies there are a lot of patients still looking for help to get a better life. This treatment might be an excellent option for them," said Plazier, a neurosurgeon at University Hospital Antwerp. But, "it is difficult to determine the impact of these findings on fibromyalgia patients, since larger trials ... are necessary."
Plazier is to present his research this week at a meeting of the
International Neuromodulation Society, in Berlin. Neuromodulation
is a group of therapies that use medical devices to relieve
symptoms or restore abilities by altering nerve system
Research presented at scientific conferences has not typically
been peer-reviewed or published and is considered preliminary.
Fibromyalgia is thought to affect about 5 million American
adults -- most of them women -- according to the U.S. National
Institutes of Health. The cause of the disorder, which can also
involve sleep problems, anxiety and depression, is unknown and it
can be difficult to treat.
Plazier also presented a separate study on six fibromyalgia
patients using PET scan images to visualize brain changes from
occipital nerve stimulation treatment. It suggested that the nerve
stimulation changes activity in the limbic system, a brain region
that helps determine pain perception.
"In fibromyalgia, we see that there is a hypervigilance to pain, so patients are more sensitive to pain and more aware of it," Plazier said. "They also have high scores on questionnaires concerning catastrophizing behavior, which implies the high impact of pain on their lives."
"During [occipital nerve] stimulation we see differences in brain activity on PET scans in regions involved in pain," he added. "This all might suggest that we are influencing a cerebral system and might even turn it back to 'normal' perception."
Study participants didn't find the nerve-zapping treatment to be
painful, Plazier noted. The occipital nerve stimulation device is
implanted during a brief surgery using general anesthesia, he said,
and postoperative pain is normal but not extreme.
Dr. Patrick Wood, director of the fibromyalgia clinic at Madison
River Oaks Medical Center in Canton, Miss., called the studied
"interesting and promising" but said additional research is
necessary before treatment with occipital nerve stimulation --
which may cost around $10,000 -- could become mainstream for
"It's mostly used in headaches, and even in the headache realm it's still considered experimental," Wood said. "It would be nice to have expanded data here that would indicate there's something worth banking on and putting our hopes on. It's promising, but more work needs to be done before the average patient can consider it."
The U.S. National Institute of Arthritis and Musculoskeletal and
Skin Diseases has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.